Drugs / CXLO Corneal Strengthening Solution
CXLO Corneal Strengthening Solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03029104 Background | Dec 2016 → Dec 2020 | keratoconus, photosensitivity disease | Cxlusa | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CXLO Corneal Strengthening Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03029104 ↗ |
| Modality | Other / unclassified | “epi-on crosslinking system” PMID 36173242 ↗ Sep 2022 |